Cargando…
Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
Vitamin K antagonists are being used in the last five decades as an effective anticoagulant. However, for the past few years, new oral anticoagulants (NOACs) have been introduced as newer anticoagulant agents, which are gradually replacing the previously used vitamin K antagonist. Yet, these agents...
Autores principales: | Khan, Yusra, Zaidi, Syed Owais, Razak, Bibi S, Zaki, Mariann, Malik, Bilal Haider |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077741/ https://www.ncbi.nlm.nih.gov/pubmed/32206471 http://dx.doi.org/10.7759/cureus.7007 |
Ejemplares similares
-
The Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients With Atrial Fibrillation: A Network Meta-Analysis
por: Salah, Qais M, et al.
Publicado: (2023) -
Insight Into the Perioperative Management of Type 2 Diabetes
por: Zaidi, Syed Owais, et al.
Publicado: (2020) -
Obesity Paradox in Atrial Fibrillation and its Relation with the New Oral Anticoagulants
por: Filho, André Inocêncio Novaes Lima, et al.
Publicado: (2022) -
Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020) -
New horizons in anticoagulation: Direct oral
anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)